A new blood test detected Alzheimer's disease as accurately as expensive brain scans or spinal taps, raising the possibility for a new, inexpensive option to diagnose the most common form of dementia, researchers said.
A new blood test detected Alzheimer's disease as accurately as expensive brain scans or spinal taps, raising the possibility for a new, inexpensive option to diagnose the most common form of dementia, researchers said.
A blood test to detect Alzheimer's disease early could be more precise than memory and thinking tests now used to diagnose the disease. Invasive and expensive brain scans and spinal taps that measure spinal fluid are used, but insurance does not always cover those tests. "It is a promising blood test that seems to be highly accurate and seems to detect relatively early," said Dr. Eric Reiman, a researcher in one of the studies and executive director of Banner Alzheimer's Institute in Phoenix
Randall J. Bateman, a Washington University neurology professor and Alzheimer's researcher, said blood tests could be useful both for patients and doctors as well scientists studying new drugs to slow the mind-robbing disease.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
'No complexity at all': Vaccines are safe, study looking at 20 years worth of data concludesAfter a vaccine hits the market, safety surveillance continues.
続きを読む »
New Study May Help 'Predict' Who Will Get Severe COVID-19 CasesRecent research shows that people typically fall into one of six different clusters of coronavirus symptoms.
続きを読む »
Wearing a face mask fools facial recognition algorithms, study finds - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidateGerman biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
続きを読む »
'The main event': Moderna begins final phase of COVID-19 vaccine study'This research study is something that I can do personally to benefit ... humanity,' said one volunteer. Thousands more are needed.
続きを読む »